Cancer Vaccine Institute News

Dr. Nora Disis, CVI Director, and Dr. Nicole Kretzer, Clinical Acting Instructor, spoke this past Friday, October 14th as part of...

Dr. Nora Disis (CVI Director) was featured in a New York Times article this week. Dr. Disis shares the promise of our STEMVAC vaccine for...

Dr. Nora Disis and the CVI team had a great time participating in the Valley Girls & Guys! Be the Hope Walk this past Saturday, July 16!...

The Cancer Vaccine Institute will hold a series of virtual seminars during June and July 2022. The five-part seminar series is an...

The CVI's Dr. Nora Disis (Director) and Dr. Kiran Dhillon (Executive Director), along with other colleagues from UW Medicine and Fred...

We’re delighted to announce that the Seattle Chapter of Association for Women in Science (AWIS) has announced that Dr. Nora Disis, CVI...

In 2021, our Cancer Vaccine Institute team worked relentlessly toward our efforts to ignite the immune system to end cancer. To learn...

The Clinical Trials Affinity Group at Fred Hutch will be hosting Leigh Pate on the topic of “Participation in Clinical Trials: A...

Breast Cancer Alliance, a longtime supporter of breast cancer research at the Cancer Vaccine Institute, is celebrating its 25th...

Cancer Vaccine Institute volunteers Norm Slonaker, Susan Bevan, and Kristi Blair, recently hosted a virtual event called “Gut Check” with...

We are excited to share that Dr. Andrew Coveler has been appointed Interim Director of Clinical Trials at the Cancer Vaccine Institute....

When Bridgette Hempstead was diagnosed with breast cancer at age 35, she realized that there were very few resources available for black women with breast cancer. In fact, while incredible leaps have been made in breast and other cancer care, black, Hispanic, and other communities of color tend to be diagnosed at more advanced stages of breast cancer and have worse outcomes. Bridgette wants to change these statistics by providing support, education, and advocacy for members

Safeway/Albertsons’ Women’s Inspiration and Inclusion Network (WIIN) invited Dr. Nora Disis, CVI Director, to a discussion moderated by...

The Cancer Vaccine Institute is proud to recognize Stephanie N. today! Stephanie was diagnosed with HER2-positive breast cancer in 2000...

Ovarian cancer is a deadly disease that affects one in 78 women. While therapies that activate the immune system have been effective in...

Dr. Andrew Coveler is the Interim Director of Clinical Trials at the Cancer Vaccine Institute. He was selected by his peers as one of...

The UW Medicine Cancer Vaccine Institute is dedicated to a single mission: igniting the immune system to end cancer. Achieving excellence...

Guest post by Christine Chan and Hollie Seiler, UW Medicine Advancement A few months ago, our CVI Development Council members encouraged...

Dr. Nora Disis accepts check, in honor of Sydney Berry’s retirement from Salon Services, at the Valley Girls and Guys annual Be The Hope...

Kim was diagnosed with stage IIIC ovarian cancer on September 28, 2009. She had experienced some of the classic symptoms of ovarian...